🇺🇸 FDA
Pipeline program

Ultomiris 300 mg/30 mL concentrate for solution for infusion, Concentrate for solution for infusion

ALXN1210-NEPH-202

Phase 2 small_molecule active

Quick answer

Ultomiris 300 mg/30 mL concentrate for solution for infusion, Concentrate for solution for infusion for Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN) is a Phase 2 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).

Program details

Company
Alexion Europe SAS
Indication
Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials